Avoid common mistakes on your manuscript.
A 58-year-old man had a 5-day history of high fever and cough. He suffered from hypoxia, and chest computed tomography (CT) showed multiple pulmonary ground-glass opacities bilaterally (Fig. 1a). He was diagnosed with coronavirus disease 2019 (COVID-19) and admitted to our hospital. Electrocardiogram showed pathological Q waves, ST-segment elevation, and inverted T waves in precordial leads (Fig. 1b), suggesting anteroseptal myocardial infarction (MI), whereas he never had chest pain. Transthoracic echocardiography (TTE) revealed an akinetic anteroseptal wall and a left ventricular (LV) apical aneurysm. In addition, an isoechoic immobile mass, suspected of being a mural thrombus, was visualized along the aneurysm (Fig. 1c; Videos 1, 2). Since COVID-19 induces hypercoagulability and cardiovascular inflammation with a variety of cardiac manifestations [1], we hypothesized that these cardiac abnormalities were associated with COVID-19. However, neither cardiac troponin nor d-dimer was elevated through the repetitive measurements, which was inconsistent with the assessment. He was hemodynamically stable and did not require emergent coronary angiogram. Coronary CT revealed not only severe stenosis of the proximal left anterior descending artery (LAD) but also a low-density mass compatible with a LV thrombus in the apical aneurysm (Fig. 1d). In addition to oxygenation, he was treated with favipiravir and dexamethasone for COVID-19 [2, 3], continuous heparin for the suspected LV thrombus, and antianginal drugs for MI. On day 5, the fever abated and hypoxia resolved. The additional ischemic electrocardiographic changes evoked by walking had him undergo revascularization for LAD (Fig. 1e, f). Anticoagulation with warfarin was continued for 3 months; however, the LV mass did not resolve (Video 3). Since cardiac magnetic resonance imaging was rejected due to claustrophobia, three-dimensional (3D) TTE was performed. The 3D apical view demonstrated trabecular formation crosslinking to septal and lateral walls, suggesting that the LV mass was myocardial trabeculation, not a thrombus (Fig. 1g; Videos 4–6); however, the possibility of a concomitant invisible tiny thrombus adjacent to the trabeculation remained. Regardless of a history of COVID-19, he previously developed silent MI, and the atypical LV trabeculation mimicked a LV thrombus. Since the TTE appearance of LV thrombi varies from case to case depending on thrombus age, morphology, and location, two-dimensional imaging has a certain limitation [4]. 3D TTE can be used as a complementary tool as it allows visualization of cardiac structures independent of the availability of specific acoustic windows [5]. In the present case, it allowed us to identify the mass as myocardial trabeculation and successfully resolve our misunderstanding.
References
Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res. 2021;117:2705–29.
Shiraki K, Sato N, Sakai K, et al. Antiviral therapy for COVID-19: derivation of optimal strategy based on past antiviral and favipiravir experiences. Pharmacol Ther. 2022. https://doi.org/10.1016/j.pharmthera.2022.108121.
van de Veerdonk FL, Giamarellos-Bourboulis E, Pickkers P, et al. A guide to immunotherapy for COVID-19. Nat Med. 2022;28:39–50.
Turhan S, Ozcan OU, Erol C. Imaging of intracardiac thrombus. Cor Vasa. 2013;55:e176–83.
Atici A, Asoglu R, Demirkiran A, et al. Impact of multimodality imaging on the diagnosis of left ventricular apical thrombus in patients after anterior myocardial infarction. Am J Med Sci. 2022;363:130–9.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Kei Takahashi, Toru Egashira, Toshimi Kageyama, Tetsuo Oumi, Shigeo Shimizu, Kazunori Moritani, and Hideo Mitamura declare that they have no conflicts of interest.
Ethical approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent was obtained in the form of an opt-out selection.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Video 1: A zoomed 2D apical transthoracic four-chamber view showed a thin LV apex compatible with aneurysm formation. An isoechoic immobile mass was visualized along the aneurysm. This is the movie for Fig. 1c (MP4 1299 KB)
Video 2: An isoechoic immobile mass in a zoomed 2D apical transthoracic two-chamber view in the same study with Video 1 (MP4 1194 KB)
Video 3: The mass appeared unchanged after 4-month optimal anticoagulation using continuous heparin and warfarin in a zoomed 2D apical transthoracic two-chamber view. The successful revascularization for LAD provided improvement of left ventricular wall motion (MP4 1400 KB)
Video 4: The mass in the X-plane image of 3D echo with an oblique slice of apical two-chamber view (left panel) and a left–right inverted four-chamber view (right panel) (MP4 989 KB)
Video 5: A zoomed 3D apical transthoracic four-chamber view showed a mass-like myocardial trabeculation appearing forming crosslinking to LV septal and lateral walls. This is the movie for Fig. 1g (MP4 676 KB)
Video 6: A zoomed 3D axial slice of the apex showed a mass-like myocardial trabeculation appearing forming crosslinking to LV septal, anterior, and lateral walls (MP4 764 KB)
About this article
Cite this article
Takahashi, K., Egashira, T., Kageyama, T. et al. Three-dimensional transthoracic echocardiography successfully identified myocardial trabeculation mimicking left ventricular apical thrombus in a patient with COVID-19. J Med Ultrasonics 50, 259–261 (2023). https://doi.org/10.1007/s10396-023-01297-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10396-023-01297-9